Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 20;9(1):e790.
doi: 10.1002/ams2.790. eCollection 2022 Jan-Dec.

Comparison of the efficacy of continuous intravenous infusion versus intramuscular injection of epinephrine for initial anaphylaxis treatment

Affiliations

Comparison of the efficacy of continuous intravenous infusion versus intramuscular injection of epinephrine for initial anaphylaxis treatment

Kenji Fujizuka et al. Acute Med Surg. .

Abstract

Aim: Continuous intravenous (CIV) infusion of epinephrine for the treatment of anaphylaxis may be required if symptoms do not improve after intramuscular (IM) injection. As CIV infusion permits precise dose adjustment, we compared treatment course and adverse events following CIV infusion and IM injection of epinephrine for the management of anaphylaxis.

Methods: Medical records of patients, who were treated for anaphylaxis with epinephrine, were 18 years or older, and were admitted to our department from April 2005 to March 2016, were retrospectively reviewed. The cases were categorized as CIV infusion or IM injection, and treatment course and outcomes were compared between the two groups.

Results: Of the 142 eligible cases, there were 78 in the CIV infusion group and 64 in the IM injection group. The CIV infusion group had lower systolic blood pressure, more respiratory symptoms, and higher Acute Physiology and Chronic Health Evaluation II (APACHE II) scores, but required a lower total dose of epinephrine, had fewer adverse events after epinephrine administration, and showed lower incidence of biphasic reactions. In addition, compared with the IM injection group, time to administration of epinephrine was significantly longer (P < 0.001), but time to resolution of symptoms, both from contact and epinephrine administration, was significantly shorter (P < 0.01 and P = 0.03, respectively).

Conclusion: Continuous intravenous infusion of epinephrine for the treatment of anaphylaxis may be safe, has fewer adverse events, improves symptoms, and is relatively easy to administer under ready conditions. CIV infusion of epinephrine may also reduce the incidence of biphasic reactions.

Keywords: adverse event; anaphylaxis; biphasic reaction; epinephrine; intravenous infusion.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Time interval from patient contact to resolution of symptoms. (A) Time from contact to administration of epinephrine. (B) Time from administration of epinephrine to resolution of symptoms. (C) Time from contact to resolution of symptoms.
Fig. 2
Fig. 2
Flow diagram showing case selection. c.i.v., continuous intravenous infusion; i.m., intramuscular injection; i.v., intravenous injection.

Similar articles

Cited by

References

    1. Simons FER. Anaphylaxis. J. Aller. Clin. Immunol. 2010; 125: S161–81. - PubMed
    1. Nandinee P, Kok WC, Alexander YGY et al. Use of multiple epinephrine doses in anaphylaxis: a systematic review and meta‐analysis. J. Aller. Clin. Immunol. 2021; 148: 1307–15. - PMC - PubMed
    1. Soar J, Pumphrey R, Cant A et al. Emergency treatment of anaphylactic reactions—guidelines for healthcare providers. Resuscitation 2008; 77: 157–69. - PubMed
    1. Mink SN, Simons FE, Simons KJ, Becker AB, Duke K. Constant infusion of epinephrine, but not bolus treatment, improves haemodynamic recovery in anaphylactic shock in dogs. Clin. Exp. Allergy 2004; 34: 1776–83. - PubMed
    1. Brown SG, Blackman KE, Stenlake V, Heddle RJ. Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emerg. Med. J. 2004; 21: 149–54. - PMC - PubMed